当前位置:首页 - 行情中心 - 新华制药(000756) - 财务分析

新华制药

(000756)

  

流通市值:61.61亿  总市值:86.04亿
流通股本:4.99亿   总股本:6.97亿

新华制药(000756)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润0.83亿元,每股收益0.12元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益559586.15万元,未分配利润273065.91万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产906892.80万元,负债347306.64万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入2,423,049,619.18,754,721,987.786,762,620,901.324,638,804,042.98
营业总成本2,313,460,629.838,390,212,699.236,434,132,318.54,343,477,881.12
其他经营收益
营业利润119,032,957.94363,984,851.26311,801,703.75264,247,207.11
利润总额118,632,777.91358,916,503.18305,996,579.37263,527,198.08
净利润83,267,243.86306,303,918.15266,908,611.57231,168,471.79
每股收益
其他综合收益-23,698,036.7726,020,010.31-5,083,975.6214,538,742.98
综合收益总额59,569,207.09332,323,928.46261,824,635.95245,707,214.77
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计4,051,810,002.714,033,472,605.463,898,783,848.793,992,086,651
非流动资产:
非流动资产合计5,017,117,949.065,152,223,162.75,194,956,279.235,245,567,136.32
资产总计9,068,927,951.779,185,695,768.169,093,740,128.029,237,653,787.32
流动负债:
流动负债合计2,296,763,831.542,811,202,439.762,982,354,718.833,152,193,045.88
非流动负债:
非流动负债合计1,176,302,610.25918,766,825.16720,990,703.28720,468,215.87
负债合计3,473,066,441.793,729,969,264.923,703,345,422.113,872,661,261.75
所有者权益(或股东权益):
归属于母公司股东权益合计5,349,787,689.695,208,753,244.525,149,027,624.515,126,743,297.32
股东权益合计5,595,861,509.985,455,726,503.245,390,394,705.915,364,992,525.57
负债和股东权益合计9,068,927,951.779,185,695,768.169,093,740,128.029,237,653,787.32
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计1,916,322,024.47,931,827,672.465,857,712,171.913,877,227,440.33
经营活动现金流出小计2,032,874,727.497,398,098,964.725,535,713,308.943,643,095,087.6
经营活动产生的现金流量净额-116,552,703.09533,728,707.74321,998,862.97234,132,352.73
投资活动产生的现金流量:
投资活动现金流入小计844,70012,098,525.7710,724,588.293,568,460.69
投资活动现金流出小计27,430,037.86115,602,127.29106,668,229.9379,807,920.68
投资活动产生的现金流量净额-26,585,337.86-103,503,601.52-95,943,641.64-76,239,459.99
筹资活动产生的现金流量:
筹资活动现金流入小计361,340,450.51,041,232,461810,637,524.5517,377,524.5
筹资活动现金流出小计349,537,798.851,332,360,679.021,054,754,499.69654,093,784.12
筹资活动产生的现金流量净额11,802,651.65-291,128,218.02-244,116,975.19-136,716,259.62
汇率变动对现金及现金等价物的影响2,343,164.687,237,015.536,124,226.965,778,620.84
现金及现金等价物净增加额-128,992,224.62146,333,903.73-11,937,526.926,955,253.96
期末现金及现金等价物余额1,154,216,689.171,283,208,913.791,124,937,483.161,163,830,264.02
补充资料:
现金及现金等价物的净增加额-146,333,903.73-26,955,253.96
TOP↑